'Hen Factories' To Synthesize Cancer Drugs
...noclonal antibodies, are produced commercially in industrial bioreactors. This method is time-consuming, besides being expensive. The use of the avian biosystem
as bioreactors for the production of human biopharmaceuticals is cheaper, faster, more efficient, besides the raw material required being just 'bird f...
Governors business-plan contest has a surprise ending
...ce Wednesday evening in Milwaukee, Middleton-based biosystem
Development and Milwaukee-based NovaScan will spli... forth if given a chance.
Development: Alternative lab testing ($27,500)
Scott Fulton of biosystem
Development said his product idea came from mmune-...
Governors business-plan competition starts another round
...ne. The grand prize had to be split between two companies, Middleton-based biosystem
Development and Milwaukee-based NovaScan.
Read about the resolution o...arket are the best ones in the judges estimation.
Last year the plans of biosystem
Development, a Middleton-based analytical firm founded by biotechnology con...
Madison biotechs get Commerce grants
...rough the Department of Commerce Technology Assistance Grant program.
Development LLC of Middleton, will receive $11,250 to assist in its develo...r intellectual property situation well under control," said Scott Fulton, a biosystem
The second grant recipient, Quintessence Biosciences o...
Business plan finalists offer peek into entrepreneurial future
...ar's field of 27 finalists should produce a Grand Prize winner that continues the trend begun by start ups like Mithridion, Inc., the 2005 winner, and biosystem
Development and NovaScan, who tied for first in 2004.
As is the custom, the winner will be announced on the first day of the annual Wisconsin Entre...
BioSystem Development secures angel funding
...nsin sources, Silicon Pastures and Marshfield Investment Partners .
Development, LLC , which was founded in 2002, will receive $465,000 from Si...irector of Silicon Pastures, said a lack of monetary capital was preventing biosystem
from building and delivering the biomedical device to customers.